LCM
RVMD icon

Legato Capital Management’s Revolution Medicines RVMD Stock Holding History

Legato Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.19M Sell
33,042
-4,352
-12% -$636K 0.51% 29
2026
Q1 		$3.64M Sell
37,394
-11,357
-23% -$1.15M 0.33% 76
2025
Q4 		$3.88M Buy
48,751
+14,097
+41% +$924K 0.33% 51
2025
Q3 		$1.62M Buy
34,654
+19,637
+131% +$769K 0.18% 167
2025
Q2 		$552K Buy
15,017
+7,283
+94% +$280K 0.07% 424
2025
Q1 		$273K Sell
7,734
-2,979
-28% -$121K 0.04% 497
2024
Q4 		$469K Buy
10,713
+3,167
+42% +$160K 0.06% 447
2024
Q3 		$342K Sell
7,546
-12,653
-63% -$551K 0.04% 491
2024
Q2 		$784K Buy
+20,199
New +$755K 0.11% 322

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Legato Capital Management's RVMD Position: Q2 2026 in Review

Legato Capital Management reduced its Revolution Medicines (RVMD) stake by 12% in Q2 2026, selling an estimated $636K and leaving 33,042 shares worth $6.19M. The position accounts for 0.51% of the portfolio, ranked #29.

Legato Capital Management first reported a position in RVMD in Q2 2024 and has held it in 9 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Legato Capital Management held 33,042 shares of Revolution Medicines worth $6.19M as of Q2 2026.
  • Legato Capital Management sold 4,352 Revolution Medicines shares in Q2 2026, an estimated $636K.
  • Revolution Medicines made up 0.51% of Legato Capital Management's portfolio in Q2 2026, its #29 holding.
  • Legato Capital Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 9 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.